4,897 results on '"Hoos, A."'
Search Results
452. Die Welt in Frieden: Waffen aus Glas in Händen aus Stahl
453. Analysing differences between algorithm configurations through ablation.
454. SATenstein: Automatically building local search SAT solvers from components.
455. ASlib: A benchmark library for algorithm selection.
456. Automated Algorithm Selection and Configuration (Dagstuhl Seminar 16412).
457. Identifying automation components in modular manufacturing systems: A method for modeling dependencies of manufacturing systems.
458. Surrogate Benchmarks for Hyperparameter Optimization.
459. ValueApping: An Analysis Method to Identify Value-Adding Mobile Enterprise Apps in Business Processes.
460. Improving Business Processes Through Mobile Apps - An Analysis Framework to Identify Value-added App Usage Scenarios.
461. Evaluating Instance Generators by Configuration.
462. Algorithm Configuration in the Cloud: A Feasibility Study.
463. AClib: A Benchmark Library for Algorithm Configuration.
464. An Efficient Approach for Assessing Hyperparameter Importance.
465. Algorithm Configuration in the Cloud: A Feasibility Study
466. Evaluating Instance Generators by Configuration
467. AClib: A Benchmark Library for Algorithm Configuration
468. Developing Cancer Immunotherapies as Drugs: Setting the Stage Through Methodological Progress
469. VPint: value propagation-based spatial interpolation
470. VNF chain abstraction for cloud service providers.
471. Automating Data Science.
472. COVERING NEW GROUND.
473. Industrializing engineered autologous T cells as medicines for solid tumours
474. Automated Algorithm Selection: Survey and Perspectives.
475. Leveraging TSP Solver Complementarity through Machine Learning.
476. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients
477. RSVpredict: An Online Tool to Calculate the Likelihood of Respiratory Syncytial Virus Infection in Children Hospitalized With Acute Respiratory Disease
478. Social entrepreneurship and social impact assessment
479. Stochastic Local Search
480. Empirical Analysis of Randomised Algorithms
481. Foreword.
482. Special issue on 'Stochastic Local Search: Recent developments and trends'.
483. LSQ++: Lower Running Time and Higher Recall in Multi-codebook Quantization
484. Algorithm Configuration Landscapes
485. Challenges and solutions for instituting an efficient maintenance program for laboratory equipment in Central Asian, and developing world, countries
486. Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
487. Risk Factors for Enteric Pathogen Exposure among Children in Black Belt Region of Alabama, USA.
488. Introducing the enterprise data marketplace: a platform for democratizing company data.
489. CCR Translation for the Article from Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
490. Supplementary Data from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
491. Supplementary figure 2 from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
492. Figure S1 from Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
493. Table S1 from Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
494. Supplementary figure 1 from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
495. Supplementary tables S1-S6 from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
496. Supplementary Figure legends from Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
497. Data from Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
498. Supplementary Table 1 from Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
499. Supplementary Methods, References from Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
500. Supplementary Figure Legend from Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.